Search Tag: semaglutide

Cardiology Management

2023 05 Sep

Novo Nordisk, the Danish pharmaceutical giant behind the weight-loss medication Wegovy (active ingredient - semaglutide), has become Europe's most valuable company, dethroning the French luxury conglomerate LVMH.   Following the successful launch of Wegovy in the U.K., the company's shares saw a significant uptick in value. As trading closed...Read more